Wilmington, DE and Ashdod, Israel, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring ...
ASHKELON, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement ...
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring ...
WILMINGTON, Del. & ASHDOD, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring glucose levels in people with Type 2 ...
Wilmington, DE and Or Yehuda, Israel, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for ...
Integrity Applications Common Stock is Publicly Quoted on the OTC Bulletin Board under the Symbol "I
Integrity Applications Common Stock is Publicly Quoted on the OTC Bulletin Board under the Symbol "IGAP" Raises approximately $6.3 million to advance the development and commercialization of ...
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring D
ASHKELON, Israel--(BUSINESS WIRE)-- Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement ...
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring D
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring Device ASHKELON, Israel--(BUSINESS WIRE)-- Integrity Applications, Inc. (OTC/QB: IGAP) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback